Michael Griffin
Stock Analyst at Citigroup
(2.94)
# 1,613
Out of 4,749 analysts
13
Total ratings
100%
Success rate
23.34%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Griffin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CBRE CBRE Group | Maintains: Buy | $130 → $160 | $144.74 | +10.54% | 5 | Nov 25, 2024 | |
| AHR American Healthcare REIT | Initiates: Neutral | $14 | $28.29 | -50.51% | 1 | Mar 4, 2024 | |
| JLL Jones Lang LaSalle | Maintains: Neutral | $178 | $282.80 | -37.06% | 3 | Sep 18, 2023 | |
| HR Healthcare Realty Trust | Maintains: Neutral | $19 → $17 | $16.75 | +1.49% | 2 | Aug 22, 2023 | |
| HPP Hudson Pacific Properties | Maintains: Neutral | $5 → $4.5 | $3.13 | +43.77% | 2 | May 19, 2023 |
CBRE Group
Nov 25, 2024
Maintains: Buy
Price Target: $130 → $160
Current: $144.74
Upside: +10.54%
American Healthcare REIT
Mar 4, 2024
Initiates: Neutral
Price Target: $14
Current: $28.29
Upside: -50.51%
Jones Lang LaSalle
Sep 18, 2023
Maintains: Neutral
Price Target: $178
Current: $282.80
Upside: -37.06%
Healthcare Realty Trust
Aug 22, 2023
Maintains: Neutral
Price Target: $19 → $17
Current: $16.75
Upside: +1.49%
Hudson Pacific Properties
May 19, 2023
Maintains: Neutral
Price Target: $5 → $4.5
Current: $3.13
Upside: +43.77%